KCNH2 and torsades de pointes: The link between inhibition of IKr by common medications and QT interval prolongation, increased risk of torsades de pointes and sudden death in susceptible individuals prompted routine safety assessment of compounds during early stages of drug development for their propensity to block hERG1 channels.